Subscribe
A worldwide window to Cambridge business, innovation and technology
$40m 'Superman' backed fund partners with Healx to fight paralysis

$40m 'Superman' backed fund partners with Healx to fight paralysis

A $40 million London-based fund backed by the Christopher & Dana Reeve Foundation, among others, today unveils its first major investment – and Cambridge AI drug discovery company Healx is the beneficiary.
Wellcome Sanger Institute pursues fresh frontiers to build on rich genomics legacy

Wellcome Sanger Institute pursues fresh frontiers to build on rich genomics legacy

The Wellcome Sanger Institute in Cambridge is investigating potential new areas of genomics techniques – still restless for progress despite having mapped the Human Genome exactly 25 years ago today.
AnthroTek closes £950k seed round and eyes £12m valuation

AnthroTek closes £950k seed round and eyes £12m valuation

Exciting Cambridge startup AnthroTek has clinched £950,000 in seed funding at a pre-money valuation of £10.5 million. The company projects this valuation will rise to around £12m on completion of an additional £550k tranche expected within the next 12 months.
San Jose Sharks devour AI from Cambridge Consultants

San Jose Sharks devour AI from Cambridge Consultants

The NHL’s San Jose Sharks have collaborated with Cambridge Consultants, the DeepTech powerhouse of Capgemini, and leading sports advisory firm Sportsology to explore new approaches in ice hockey coaching through the adoption of AI in sport.
Oxbridge Techbio startup aims to reinvent AI drug discovery

Oxbridge Techbio startup aims to reinvent AI drug discovery

Academics from Oxford and Cambridge Universities and seasoned life sciences entrepreneurs have launched Symbiotic.blue, a new Techbio company which is raising a pre-seed financing round to build its artificial intelligence-driven drug discovery (AIDD) platform and initiate early-stage discovery programs.
Academia
Sharewatch
Manufacturing
Cambridge scientists' findings could counteract genetic damage of some chemotherapy treatments
01 Jul 2025 - 12:00
The changing face of entrepreneurial success – younger, female, global
01 Jul 2025 - 12:00
Wellcome Sanger Institute pursues fresh frontiers to build on rich genomics legacy
26 Jun 2025 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

The changing face of entrepreneurial success – younger, female, global

The changing face of entrepreneurial success – younger, female, global

The face of entrepreneurial success has changed significantly over the past decade with more age and gender diversity among the highest achievers than ever before.
Natalie Minott named new Head of Office for HCR Hewitsons Cambridge

Natalie Minott named new Head of Office for HCR Hewitsons Cambridge

Law firm HCR Hewitsons has a new head of office in Cambridge. Real Estate disputes partner Natalie Minott succeeds Inger Anson in the role.
Nu Quantum CEO wants more collaboration to fast-track quantum computing

Nu Quantum CEO wants more collaboration to fast-track quantum computing

Transatlantic startup Nu Quantum, steered from Cambridge UK, has morphed from contributor to conductor in a fresh initiative designed to accelerate the growth of quantum computing.
$40m 'Superman' backed fund partners with Healx to fight paralysis

$40m 'Superman' backed fund partners with Healx to fight paralysis

A $40 million London-based fund backed by the Christopher & Dana Reeve Foundation, among others, today unveils its first major investment – and Cambridge AI drug discovery company Healx is the beneficiary.
More news

Tech trail

$40m 'Superman' backed fund partners with Healx to fight paralysis

$40m 'Superman' backed fund partners with Healx to fight paralysis

A $40 million London-based fund backed by the Christopher & Dana Reeve Foundation, among others, today unveils its first major investment – and Cambridge AI drug discovery company Healx is the beneficiary.
Cambridge battery innovator making inroads in Asia

Cambridge battery innovator making inroads in Asia

A Cambridge company is making waves in Asia’s battery sector with a novel material that delivers faster charging and improved safety for industrial vehicles.
Serve First raises £4.6m to expand AI into Europe and US

Serve First raises £4.6m to expand AI into Europe and US

Serve First, an AI-driven customer experience and feedback management platform with its HQ in Milton Keynes, has raised £4.6 million from Pembroke VCT and the Midlands Engine Investment Fund II, through its appointed fund manager Mercia Ventures, alongside Tiny VCT, Techstars and angel investors.
University of Cambridge spinout Trismik raises funding to target market worth billions

University of Cambridge spinout Trismik raises funding to target market worth billions

Cambridge tech tyro Trismik is understood to have raised new but as yet unspecified funding from a range of sources as it opens up new $multibillion markets at the forefront of AI.
More Tech trail

Trade floor

Nu Quantum CEO wants more collaboration to fast-track quantum computing

Nu Quantum CEO wants more collaboration to fast-track quantum computing

Transatlantic startup Nu Quantum, steered from Cambridge UK, has morphed from contributor to conductor in a fresh initiative designed to accelerate the growth of quantum computing.
Malaysia in the LOOP for Levidian technology

Malaysia in the LOOP for Levidian technology

Cambridge ClimateTech doyen Levidian Nanosystems has further clinched significant global glory as it continues to decarbonise some of the world's most carbon-intensive industries. Its patented LOOP technology has now been chosen by Gas Malaysia Berhad.
PEM’s corporate finance team advises on sale of Greenhouses Direct

PEM’s corporate finance team advises on sale of Greenhouses Direct

Cambridge-based PEM has advised the shareholders of Greenhouses Direct Limited on the sale of the business to Mirabel Group Limited and Kantik Limited for an undisclosed sum.
AstraZeneca steers another potential blockbuster drug

AstraZeneca steers another potential blockbuster drug

Cambridge-based AstraZeneca looks like it has set another drug on its way to blockbuster status – Datroway, for the treatment of lung cancer. Datroway has just been approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer and AZ has high hopes for the treatment.
Cambridge collaborators aim to develop treatments for diseases that cause dementia

Cambridge collaborators aim to develop treatments for diseases that cause dementia

Cambridge-based Enhanced Genomics, which is pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases has announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.
More Trade floor